K131287 is an FDA 510(k) clearance for the CARDIOSLEEVE. Classified as Stethoscope, Electronic (product code DQD), Class II - Special Controls.
Submitted by Rijuven Corp (Crofton, US). The FDA issued a Cleared decision on June 24, 2013 after a review of 49 days - a notably fast clearance cycle.
This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1875 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.
Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.
View all Rijuven Corp devices